PPAR Research / 2008 / Article / Fig 6

Review Article

The Development of INT131 as a Selective PPAR 𝜸 Modulator: Approach to a Safer Insulin Sensitizer

Figure 6

Glucose level in Zuker fatty rat is reduced in response to either INT131 or rosiglitazone treatment. Fourteen-day treatment with the indicated daily oral dose of INT131 or rosiglitazone in increasing doses reduce glucose levels. Adapted from [17, 19].